Grants (and workshops on the process) such as these would be useful if it was available in Australia.
———- Forwarded message ———-
From: Dr. David Scarfe <DScarfe@avma.org>
Date: Wed, Jun 12, 2013 at 5:27 AM
Subject: AquaVetMed e-News: FDA 2013 MUMS Grant Applications – Close Aug 16.
To:
June 11, 2013
FDA Announces Minor Use/Minor Species (MUMS) Grant Program Request for Applications Open Period due August 16, 2013
The Food and Drug Administration today announced the opening date for applications for grants to support the development of new animal drugs intended for minor species or minor uses in major species. (Major species are horses, dogs, cats, cattle, pigs, turkeys and chickens.) Applications are due electronically by August 16, 2013 at www.grants.gov.
The grant program was established by the Minor Use and Minor Species Animal Health Act of 2004, and funding was authorized to start after finalization of regulations to implement the Designation provisions of Section 573 of the Federal Food, Drug & Cosmetic Act.
Eligibility requirements to apply for a MUMS grant include:
- · the drug must be ‘designated’ by the Center for Veterinary Medicine’s (CVM) Office of Minor Use and Minor Species Animal Drug Development (OMUMS) under the MUMS Act;
- · the grant funding must be used to defray the costs of qualified safety and effectiveness testing expenses associated with the development of the drug for the designated intended use;
- · interested parties must have a study protocol that has been accepted by CVM’s Office of New Animal Drug Evaluation (ONADE) prior to submitting the grant application.
Qualified safety studies include those intended to support target animal safety, environmental safety, and human food safety. For human food safety, a separate study to validate an analytical method prior to conduct of an in-life study is eligible for funding, if a protocol for the stand-alone method validation study has been accepted by ONADE.
Grants will be available for up to $75,000 per year for up to two years for routine studies; and up to $125,000 per year for up to two years for studies of unusual complexity, duration or size. A third year of funding may be available for long-term toxicology studies. Therefore, grants could range from under $75,000 for a routine study that could be completed in less than a year, to $250,000 for a complex study requiring two years for completion, to $375,000 for a long-term toxicology study. Indirect costs are limited to 15% of direct costs.
The complete Request for Applications is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-003.html. Please note revisions to dates and text in Notice NOT-FD-13-014, at http://grants.nih.gov/grants/guide/notice-files/NOT-FD-13-014.html.
___________________________
AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.
If e-News information is used elsewhere please acknowledge AquaVetMed as the source. Encourage individuals to subscribe rather than distribute through list serves.
Messages may contain attachments that will have been scanned for known viruses.
Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.
Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.
Visit our website: www.avma.org
________________________________
